Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Enanta Pharmaceuticals (ENTA) over the last 9 years, with Q4 2025 value amounting to 3.65.

  • Enanta Pharmaceuticals' Interest Coverage Ratio rose 6958.19% to 3.65 in Q4 2025 from the same period last year, while for Dec 2025 it was 8.3, marking a year-over-year increase of 2883.52%. This contributed to the annual value of 11.11 for FY2025, which is 10.6% up from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Interest Coverage Ratio of 3.65 as of Q4 2025, which was up 6958.19% from 7.7 recorded in Q3 2025.
  • Enanta Pharmaceuticals' Interest Coverage Ratio's 5-year high stood at 3.65 during Q4 2025, with a 5-year trough of 18.38 in Q2 2023.
  • For the 3-year period, Enanta Pharmaceuticals' Interest Coverage Ratio averaged around 11.12, with its median value being 11.57 (2024).
  • Per our database at Business Quant, Enanta Pharmaceuticals' Interest Coverage Ratio crashed by 1835.76% in 2024 and then soared by 6958.19% in 2025.
  • Enanta Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 10.14 in 2023, then fell by 18.36% to 12.0 in 2024, then skyrocketed by 69.58% to 3.65 in 2025.
  • Its Interest Coverage Ratio stands at 3.65 for Q4 2025, versus 7.7 for Q3 2025 and 11.68 for Q2 2025.